Literature DB >> 22032949

Quantification of metabotropic glutamate subtype 5 receptors in the brain by an equilibrium method using 18F-SP203.

Yasuyuki Kimura1, Fabrice G Siméon, Sami S Zoghbi, Yi Zhang, Jun Hatazawa, Victor W Pike, Robert B Innis, Masahiro Fujita.   

Abstract

A new PET ligand, 3-fluoro-5-(2-(2-(18)F-(fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile (18F-SP203) can quantify metabotropic glutamate subtype 5 receptors (mGluR5) in human brain by a bolus injection and kinetic modeling. As an alternative approach to a bolus injection, binding can simply be measured as a ratio of tissue to metabolite-corrected plasma at a single time point under equilibrium conditions achieved by administering the radioligand with a bolus injection followed by a constant infusion. The purpose of this study was to validate the equilibrium method as an alternative to the standard kinetic method for measuring 18F-SP203 binding in the brain. Nine healthy subjects were injected with 18F-SP203 using a bolus plus constant infusion for 300 min. A single ratio of bolus-to-constant infusion (the activity of bolus equaled to that of infusion over 219 min) was applied to all subjects to achieve equilibrium in approximately 120 min. As a measure of ligand binding, we compared total distribution volume (VT) calculated by the equilibrium and kinetic methods in each scan. The equilibrium method calculated VT by the ratio of radioactivity in the brain to the concentration of 18F-SP203 in arterial plasma at 120 min, and the kinetic method calculated VT by a two-tissue compartment model using brain and plasma dynamic data from 0 to 120 min. VT obtained via the equilibrium method was highly correlated with VT obtained via kinetic modeling. Inter-subject variability of VT obtained via the equilibrium method was slightly smaller than VT obtained via the kinetic method. VT obtained via the equilibrium method was ~10% higher than VT obtained via the kinetic method, indicating a small difference between the measurements. Taken together, the results of this study show that using the equilibrium method is an acceptable alternative to the standard kinetic method when using 18F-SP203 to measure mGluR5. Although small differences in the measurements obtained via the equilibrium and kinetic methods exist, both methods consistently measured mGluR5 as indicated by the highly correlated VT values; the equilibrium method was slightly more precise, as indirectly measured by the smaller coefficient of variability across subjects. In addition, when using 18F-SP203, the equilibrium method is more efficient because it requires much less data.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22032949      PMCID: PMC3254783          DOI: 10.1016/j.neuroimage.2011.10.028

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  10 in total

Review 1.  PET physiological measurements using constant infusion.

Authors:  R E Carson
Journal:  Nucl Med Biol       Date:  2000-10       Impact factor: 2.408

Review 2.  Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers.

Authors:  N A Lassen
Journal:  J Cereb Blood Flow Metab       Date:  1992-09       Impact factor: 6.200

3.  Synthesis and simple 18F-labeling of 3-fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile as a high affinity radioligand for imaging monkey brain metabotropic glutamate subtype-5 receptors with positron emission tomography.

Authors:  Fabrice G Siméon; Amira K Brown; Sami S Zoghbi; Velvet M Patterson; Robert B Innis; Victor W Pike
Journal:  J Med Chem       Date:  2007-06-16       Impact factor: 7.446

Review 4.  Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications.

Authors:  Abdelmalik Slassi; Methvin Isaac; Louise Edwards; Alexander Minidis; David Wensbo; Jan Mattsson; Karolina Nilsson; Patrick Raboisson; Donald McLeod; Thomas M Stormann; Lance G Hammerland; Edwin Johnson
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

5.  Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography.

Authors:  R E Carson; M A Channing; R G Blasberg; B B Dunn; R M Cohen; K C Rice; P Herscovitch
Journal:  J Cereb Blood Flow Metab       Date:  1993-01       Impact factor: 6.200

6.  Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil.

Authors:  M S Gandelman; R M Baldwin; S S Zoghbi; Y Zea-Ponce; R B Innis
Journal:  J Pharm Sci       Date:  1994-07       Impact factor: 3.534

Review 7.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

8.  Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods.

Authors:  Valerie Treyer; Johannes Streffer; Matthias T Wyss; Andrea Bettio; Simon M Ametamey; Uta Fischer; Mark Schmidt; Fabrizio Gasparini; Christoph Hock; Alfred Buck
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

9.  Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB.

Authors:  Shil Patel; Terence G Hamill; Brett Connolly; Elaine Jagoda; Wenping Li; Raymond E Gibson
Journal:  Nucl Med Biol       Date:  2007-09-19       Impact factor: 2.408

10.  Metabotropic glutamate subtype 5 receptors are quantified in the human brain with a novel radioligand for PET.

Authors:  Amira K Brown; Yasuyuki Kimura; Sami S Zoghbi; Fabrice G Siméon; Jeih-San Liow; William C Kreisl; Andrew Taku; Masahiro Fujita; Victor W Pike; Robert B Innis
Journal:  J Nucl Med       Date:  2008-12       Impact factor: 10.057

  10 in total
  8 in total

1.  Characterization of [11C]PXT012253 as a PET Radioligand for mGlu4 Allosteric Modulators in Nonhuman Primates.

Authors:  Akihiro Takano; Sangram Nag; Zhisheng Jia; Mahabuba Jahan; Anton Forsberg; Ryosuke Arakawa; Per Grybäck; Guillaume Duvey; Christer Halldin; Delphine Charvin
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

Review 2.  News and views on in-vivo imaging of neurotransmission using PET and MRI.

Authors:  Christin Y Sander; Swen Hesse
Journal:  Q J Nucl Med Mol Imaging       Date:  2017-07-27       Impact factor: 2.346

3.  Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans.

Authors:  Jenna M Sullivan; Keunpoong Lim; David Labaree; Shu-Fei Lin; Timothy J McCarthy; John P Seibyl; Gilles Tamagnan; Yiyun Huang; Richard E Carson; Yu-Shin Ding; Evan D Morris
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-19       Impact factor: 6.200

4.  Population-based input function and image-derived input function for [¹¹C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorder.

Authors:  Paolo Zanotti-Fregonara; Christina S Hines; Sami S Zoghbi; Jeih-San Liow; Yi Zhang; Victor W Pike; Wayne C Drevets; Alan G Mallinger; Carlos A Zarate; Masahiro Fujita; Robert B Innis
Journal:  Neuroimage       Date:  2012-08-10       Impact factor: 6.556

5.  Synthesis and characterization in monkey of [11C]SP203 as a radioligand for imaging brain metabotropic glutamate 5 receptors.

Authors:  Fabrice G Siméon; Jeih-San Liow; Yi Zhang; Jinsoo Hong; Robert L Gladding; Sami S Zoghbi; Robert B Innis; Victor W Pike
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-11       Impact factor: 9.236

6.  Comparison of two PET radioligands, [11C]FPEB and [11C]SP203, for quantification of metabotropic glutamate receptor 5 in human brain.

Authors:  Talakad G Lohith; Tetsuya Tsujikawa; Fabrice G Siméon; Mattia Veronese; Sami S Zoghbi; Chul Hyoung Lyoo; Yasuyuki Kimura; Cheryl L Morse; Victor W Pike; Masahiro Fujita; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 7.  Application of cross-species PET imaging to assess neurotransmitter release in brain.

Authors:  Sjoerd J Finnema; Mika Scheinin; Mohammed Shahid; Jussi Lehto; Edilio Borroni; Benny Bang-Andersen; Jukka Sallinen; Erik Wong; Lars Farde; Christer Halldin; Sarah Grimwood
Journal:  Psychopharmacology (Berl)       Date:  2015-04-30       Impact factor: 4.530

8.  Design of Infusion Schemes for Neuroreceptor Imaging: Application to [(11)C]Flumazenil-PET Steady-State Study.

Authors:  Ling Feng; Claus Svarer; Karine Madsen; Morten Ziebell; Agnete Dyssegaard; Anders Ettrup; Hanne Demant Hansen; Szabolcs Lehel; Stig Yndgaard; Olaf Bjarne Paulson; Gitte Moos Knudsen; Lars Hageman Pinborg
Journal:  Biomed Res Int       Date:  2016-03-31       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.